"With new disease threats like Ebola where safety to health care workers and limiting an outbreak is extremely important, along with the upcoming flu season, the Company is seeing more interest in the RevVac™ safety syringe than ever before."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.